Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Translational Oncology|June 29, 2012
A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular ProfilesLaura K Donovan, Nicola E Potter, Tracy Warr, et al.
Genome Research|September 24, 2013
Single-cell mutational profiling and clonal phylogeny in cancerNicola E Potter, Luca Ermini, Elli Papaemmanuil, et al.
Stem Cell Reports|December 24, 2014
Genetic and functional diversity of propagating cells in glioblastomaSara G M Piccirillo, Sue Colman, Nicola E Potter, et al.
Experimental Cell Research|June 16, 2009
Astrocytoma derived short-term cell cultures retain molecular signatures characteristic of the tumour in situNicola E Potter, K Phipps, W Harkness, et al.
Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
British Journal of Haematology|May 28, 2020
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Leukemia|March 21, 2018
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemiaCaroline L Furness, Marcela B Mansur, Victoria J Weston, et al.
Blood Advances|September 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Nature Cancer|November 4, 2021
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemiaVirginia A Turati, José Afonso Guerra-Assunção, Nicola E Potter, et al.
The New England Journal of Medicine|June 9, 2016
Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
Pageof 2